Patents by Inventor Jay Thomas Backstrom

Jay Thomas Backstrom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF
    Publication number: 20230255996
    Abstract: The present disclosure provides pharmaceutical compositions comprising cytidine analogs for oral administration, wherein the compositions release the cytidine analog substantially in the stomach. Also provided are methods of treating diseases and disorders using the oral formulations provided herein.
    Type: Application
    Filed: April 24, 2023
    Publication date: August 17, 2023
    Inventors: Jeffrey B. Etter, Mei Lai, Jay Thomas Backstrom
  • ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF
    Publication number: 20230241086
    Abstract: The present disclosure provides pharmaceutical compositions comprising cytidine analogs for oral administration, wherein the compositions release the cytidine analog substantially in the stomach. Also provided are methods of treating diseases and disorders using the oral formulations provided herein.
    Type: Application
    Filed: November 10, 2022
    Publication date: August 3, 2023
    Inventors: Jeffrey B. Etter, Mei Lai, Jay Thomas Backstrom
  • Oral formulations of cytidine analogs and methods of use thereof
    Patent number: 11571436
    Abstract: The present disclosure provides pharmaceutical compositions comprising cytidine analogs for oral administration, wherein the compositions release the cytidine analog substantially in the stomach. Also provided are methods of treating diseases and disorders using the oral formulations provided herein.
    Type: Grant
    Filed: November 22, 2021
    Date of Patent: February 7, 2023
    Assignee: CELGENE CORPORATION
    Inventors: Jeffrey B. Etter, Mei Lai, Jay Thomas Backstrom
  • ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF
    Publication number: 20220105118
    Abstract: The present disclosure provides pharmaceutical compositions comprising cytidine analogs for oral administration, wherein the compositions release the cytidine analog substantially in the stomach. Also provided are methods of treating diseases and disorders using the oral formulations provided herein.
    Type: Application
    Filed: December 16, 2021
    Publication date: April 7, 2022
    Inventors: Jeffrey B. Etter, Mei Lai, Jay Thomas Backstrom
  • ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF
    Publication number: 20220079964
    Abstract: The present disclosure provides pharmaceutical compositions comprising cytidine analogs for oral administration, wherein the compositions release the cytidine analog substantially in the stomach. Also provided are methods of treating diseases and disorders using the oral formulations provided herein.
    Type: Application
    Filed: November 22, 2021
    Publication date: March 17, 2022
    Inventors: Jeffrey B. Etter, Mei Lai, Jay Thomas Backstrom
  • ISOTOPOLOGUES OF 5-AZACYTIDINE
    Publication number: 20200316099
    Abstract: The present disclosure provides pharmaceutical compositions comprising cytidine analogs for oral administration, wherein the compositions release the cytidine analog substantially in the stomach. Also provided are methods of treating diseases and disorders using the oral formulations provided herein.
    Type: Application
    Filed: March 27, 2020
    Publication date: October 8, 2020
    Inventors: John F. Traverse, William W. Leong, Jeffrey B. Etter, Mei Lai, Jay Thomas Backstrom
  • Isotopologues of 5-azacytidine
    Patent number: 10646503
    Abstract: The present disclosure provides pharmaceutical compositions comprising cytidine analogs for oral administration, wherein the compositions release the cytidine analog substantially in the stomach. Also provided are methods of treating diseases and disorders using the oral formulations provided herein.
    Type: Grant
    Filed: September 25, 2019
    Date of Patent: May 12, 2020
    Assignee: Celgene Corporation
    Inventors: John F. Traverse, William W. Leong, Jeffrey B. Etter, Mei Lai, Jay Thomas Backstrom
  • ISOTOPOLOGUES OF 5-AZACYTIDINE
    Publication number: 20200101095
    Abstract: The present disclosure provides pharmaceutical compositions comprising cytidine analogs for oral administration, wherein the compositions release the cytidine analog substantially in the stomach. Also provided are methods of treating diseases and disorders using the oral formulations provided herein.
    Type: Application
    Filed: September 25, 2019
    Publication date: April 2, 2020
    Inventors: John F. Traverse, William W. Leong, Jeffrey B. Etter, Mei Lai, Jay Thomas Backstrom
  • Isotopologues of 5-azacytidine
    Patent number: 10463683
    Abstract: The present disclosure provides pharmaceutical compositions comprising cytidine analogs for oral administration, wherein the compositions release the cytidine analog substantially in the stomach. Also provided are methods of treating diseases and disorders using the oral formulations provided herein.
    Type: Grant
    Filed: January 9, 2019
    Date of Patent: November 5, 2019
    Assignee: Celgene Corporation
    Inventors: John F. Traverse, William W. Leong, Jeffrey B. Etter, Mei Lai, Jay Thomas Backstrom
  • ISOTOPOLOGUES OF 5-AZACYTIDINE
    Publication number: 20190231803
    Abstract: The present disclosure provides pharmaceutical compositions comprising cytidine analogs for oral administration, wherein the compositions release the cytidine analog substantially in the stomach. Also provided are methods of treating diseases and disorders using the oral formulations provided herein.
    Type: Application
    Filed: January 9, 2019
    Publication date: August 1, 2019
    Inventors: John F. Traverse, William W. Leong, Jeffrey B. Etter, Mei Lai, Jay Thomas Backstrom
  • Isotopologues of 5-azacytidine
    Patent number: 10220050
    Abstract: The present disclosure provides isotopologues of 5-azacytidine.
    Type: Grant
    Filed: December 7, 2017
    Date of Patent: March 5, 2019
    Assignee: Celgene Corporation
    Inventors: John F. Traverse, William W. Leong, Jeffrey B. Etter, Mei Lai, Jay Thomas Backstrom
  • ISOTOPOLOGUES OF 5-AZACYTIDINE
    Publication number: 20180153916
    Abstract: The present disclosure provides pharmaceutical compositions comprising cytidine analogs for oral administration, wherein the compositions release the cytidine analog substantially in the stomach. Also provided are methods of treating diseases and disorders using the oral formulations provided herein.
    Type: Application
    Filed: December 7, 2017
    Publication date: June 7, 2018
    Inventors: John F. Traverse, William W. Leong, Jeffrey B. Etter, Mei Lai, Jay Thomas Backstrom
  • ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF
    Publication number: 20150374732
    Abstract: The present disclosure provides pharmaceutical compositions comprising cytidine analogs for oral administration, wherein the compositions release the cytidine analog substantially in the stomach. Also provided are methods of treating diseases and disorders using the oral formulations provided herein.
    Type: Application
    Filed: June 30, 2015
    Publication date: December 31, 2015
    Inventors: Jeffrey B. ETTER, Mei LAI, Jay Thomas BACKSTROM
  • ISOTOPOLOGUES OF 5-AZACYTIDINE
    Publication number: 20150056280
    Abstract: The present disclosure provides pharmaceutical compositions comprising cytidine analogs for oral administration, wherein the compositions release the cytidine analog substantially in the stomach. Also provided are methods of treating diseases and disorders using the oral formulations provided herein.
    Type: Application
    Filed: August 19, 2014
    Publication date: February 26, 2015
    Inventors: John F. TRAVERSE, William W. LEONG, Jeffrey B. ETTER, Mei LAI, Jay Thomas BACKSTROM
  • Oral formulations of cytidine analogs and methods of use thereof
    Patent number: 8846628
    Abstract: The present disclosure provides pharmaceutical compositions comprising cytidine analogs, for example, 5-azacytidine or decitabine, for oral administration, wherein the compositions release the cytidine analog, for example, 5-azacytidine or decitabine, substantially in the stomach. Also provided are methods of treating diseases and disorders using the oral formulations provided herein.
    Type: Grant
    Filed: May 14, 2009
    Date of Patent: September 30, 2014
    Assignee: Celgene Corporation
    Inventors: Jeffrey B. Etter, Mei Lai, Jay Thomas Backstrom
  • CYTIDINE ANALOGS FOR TREATMENT OF MYELODYSPLASTIC SYNDROMES
    Publication number: 20100311683
    Abstract: The present invention provides methods of treating a patient having a higher risk myelodysplastic syndrome, which comprises administering to a patient having a higher risk myelodysplastic syndrome a therapeutically effective amount of a cytidine analog.
    Type: Application
    Filed: November 3, 2008
    Publication date: December 9, 2010
    Inventors: C. L. Beach, Jay Thomas Backstrom
  • ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF
    Publication number: 20090286752
    Abstract: The present disclosure provides pharmaceutical compositions comprising cytidine analogs for oral administration, wherein the compositions release the cytidine analog substantially in the stomach. Also provided are methods of treating diseases and disorders using the oral formulations provided herein.
    Type: Application
    Filed: May 14, 2009
    Publication date: November 19, 2009
    Inventors: Jeffrey B. Etter, Mei Lai, Jay Thomas Backstrom